Obicetrapib for dyslipidemia with or without cardiovascular risk: A GRADE ‐assessed meta‐analysis of randomized trials with trial sequential evidence
Year: 2025
Type: article
Study designs: Systematic Review, Meta-Analysis
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.70316
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416614224
